Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium

MK Javaid, A Boyce, N Appelman-Dijkstra… - Orphanet journal of rare …, 2019 - Springer
Abstract Fibrous Dysplasia/McCune Albright syndrome (FD/MAS) represents a wide
spectrum of diseases due to somatic gain-of-function mutations of the GNAS gene. The …

[HTML][HTML] Guidelines for validation of next-generation sequencing–based oncology panels: a joint consensus recommendation of the Association for Molecular …

LJ Jennings, ME Arcila, C Corless… - The Journal of molecular …, 2017 - Elsevier
Next-generation sequencing (NGS) methods for cancer testing have been rapidly adopted
by clinical laboratories. To establish analytical validation best practice guidelines for NGS …

[HTML][HTML] Fibrous dysplasia/mccune-albright syndrome

V Szymczuk, P Florenzano, LF de Castro… - GeneReviews® …, 2024 - ncbi.nlm.nih.gov
Fibrous dysplasia/McCune-Albright syndrome (FD/MAS), the result of an early embryonic
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …

Fibrous dysplasia of bone: craniofacial and dental implications

AB Burke, MT Collins, AM Boyce - Oral diseases, 2017 - Wiley Online Library
Fibrous dysplasia (FD) is a rare bone disease caused by postzygotic somatic activating
mutations in the GNAS gene, which lead to constitutive activation of adenylyl cyclase and …

The clinical spectrum of McCune-Albright syndrome and its management

T Spencer, KS Pan, MT Collins… - Hormone research in …, 2020 - karger.com
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …

Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension

RL Benza, M Gomberg-Maitland… - American journal of …, 2015 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is a progressive fatal disease. Variable
response and tolerability to PAH therapeutics suggests that genetic differences may …

Identification of GNAS Variants in Circulating Cell‐Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome

KL Roszko, L Guthrie, X Li, MT Collins… - Journal of Bone and …, 2023 - academic.oup.com
ABSTRACT Fibrous dysplasia/McCune‐Albright syndrome (FD/MAS) is a rare mosaic bone
and endocrine disorder. Although most variants affect the GNAS R201 codon, obtaining a …

Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects

S Pepe, M Korbonits, D Iacovazzo - Journal of Endocrinology, 2019 - joe.bioscientifica.com
While 95% of pituitary adenomas arise sporadically without a known inheritable
predisposing mutation, in about 5% of the cases they can arise in a familial setting, either …

Genetic and functional analyses of TBX4 reveal novel mechanisms underlying pulmonary arterial hypertension

Y Yoshida, K Uchida, K Kodo, H Shibata… - Journal of Molecular and …, 2022 - Elsevier
Background Pulmonary arterial hypertension (PAH) is a fatal disease, with approximately
10% of cases associated with genetic variants. Recent genetic studies have reported …

Sexual precocity-genetic bases of central precocious puberty and autonomous gonadal activation

DB Macedo, LFG Silveira, DS Bessa, VN Brito… - Puberty from Bench to …, 2016 - karger.com
Precocious puberty has been classically defined as the onset of sexual secondary
characteristics in girls younger than 8 years and in boys younger than 9 years. The …